Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Campos, B.
Right arrow Articles by Baiget, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campos, B.
Right arrow Articles by Baiget, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 12:1699-1703, 2001
© 2001 European Society for Medical Oncology

research-article

BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families

B. Campos1, O. Diez1,, M. Doménech1, M. Baena1, C. Pericay2, J. Balmaña2, E. del Río1, J. Sanz2, C. Alonso2 and M. Baiget1

1Servei de Genètica, Hospital de la Santa Creu i Sant Pau Barcelona
2Servei d'Oncologia Mèdica, Hospital de la Santa Creu i Sant Pan Barcelona, Spain

O. Díez. MD, Servei de Genètica, Hospital de la Santa Creu i Sant Pau. C. Sant Antoni Ma Claret. 167 08025 Barcelona, Spain, E-mail: ODiez{at}hspsanlpau.es

Background: It is estimated that about 5%–10% of breast cancer (BC) cases is due to inherited predisposition. Early works reported that 45%–50% of site-specific BC families had BRCA1 mutations and 25%–35% BRCA2 mutations. However, these percentages could have been overestimated and likely vary among the populations studied.

Patients and methods: We analysed the BRCA2 gene in 87 Spanish breast/ovarian cancer families in which the BRCA1 mutation screening was negative.

Results: We detected 15 (17.2%) disease-causing mutations and II polymorphisms and unclassified variants. Four mutations were recurrent, and five were novel. Seven (47%) mutations were found in site-specific female BC families, five (33%) in families with OC cases, and three (20%) mutations in families with male BC cases. There was incomplete penetrance of the mutations in some families, and considerable pheno-typic variations with respect to the age of diagnosis and cancer types.

Conclusions: The percentage of mutations detected reinforces the possibility that some of these families have mutations in genes other than BRCA1 or BRCA2 that confer lower BC risks.

BRCA2, hereditary breast cancer, mutation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
E. Honrado, A. Osorio, J. Palacios, R. L. Milne, L. Sanchez, O. Diez, A. Cazorla, K. Syrjakoski, D. Huntsman, P. Heikkila, et al.
Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate BRCA2-Associated Tumors
J. Clin. Oncol., October 20, 2005; 23(30): 7503 - 7511.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. N. Weitzel, V. Lagos, K. R. Blazer, R. Nelson, C. Ricker, J. Herzog, C. McGuire, and S. Neuhausen
Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1666 - 1671.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Palacios, E. Honrado, A. Osorio, A. Cazorla, D. Sarrio, A. Barroso, S. Rodriguez, J. C. Cigudosa, O. Diez, C. Alonso, et al.
Immunohistochemical Characteristics Defined by Tissue Microarray of Hereditary Breast Cancer Not Attributable to BRCA1 or BRCA2 Mutations: Differences from Breast Carcinomas Arising in BRCA1 and BRCA2 Mutation Carriers
Clin. Cancer Res., September 1, 2003; 9(10): 3606 - 3614.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M de la Hoya, O Diez, P Perez-Segura, J Godino, J M Fernandez, J Sanz, C Alonso, M Baiget, E Diaz-Rubio, and T Caldes
Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics
J. Med. Genet., July 1, 2003; 40(7): 503 - 510.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.